![PDF] Objective response rate assessment in oncology: Current situation and future expectations | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/31979901b045184c8053075e4956319c5588d33c/4-Table1-1.png "PDF] Objective response rate assessment in oncology: Current situation and future expectations | Semantic Scholar")
PDF] Objective response rate assessment in oncology: Current situation and future expectations | Semantic Scholar
ODOMZO® (sonidegib) | Efficacy Data
Positive plasma cotinine during platinum-based chemotherapy is associated with poor response rate in advanced non-small cell lung cancer patients | PLOS ONE
ORR (Objective Response Rate) and related statistics – Part 1
Efficacy endpoints in Oncology
COTELLIC® (cobimetinib) + ZELBORAF® (vemurafenib) Objective Response Rate
ORR (Objective Response Rate) and related statistics – Part 1
Durable Response Rate
![PDF] Objective response rate assessment in oncology: Current situation and future expectations | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/31979901b045184c8053075e4956319c5588d33c/7-Figure1-1.png "PDF] Objective response rate assessment in oncology: Current situation and future expectations | Semantic Scholar")
PDF] Objective response rate assessment in oncology: Current situation and future expectations | Semantic Scholar
Clinical Trial Endpoints in Cancer Research: Four Terms You Should Know
CAR T-cell therapy shows 'high and durable response rates' in adults with B-cell ALL
Efficacy | BALVERSA® (erdafitinib) HCP
Clinical Data | JEMPERLI (dostarlimab-gxly)
Confirmed ORR and Median DOR | ENHERTU® (fam-trastuzumab deruxtecan-nxki)
Objective response rate assessment in oncology: Current situation and future expectations
iLLUMINATE - Overall Response Rate | IMBRUVICA® (ibrutinib) HCP
Updated Data for Indoximod Plus KEYTRUDA® (pembrolizumab) Demonstrate Improvement of Response Rate for Patients with Advanced Melanoma | Business Wire
Best Overall Response Rate (full analysis population) | Download Table
Forest plot of the comparison of overall response rate (ORR).
Nexcella Announces Positive 58-Patient NXC- 201 Clinical Data: 100% Overall Response Rate in light chain (AL) Amyloidosis; 92% Overall Response Rate in Multiple Myeloma at the EBMT 49th Annual Meeting in Paris
Overall response rate | Download Table
Efficacy | BALVERSA® (erdafitinib) HCP
Overall response rate | Download Table
Visualization of efficacy endpoints in oncology clinical trials
Overall Response Rates - WM | IMBRUVICA® (ibrutinib) HCP
